by Touch Stone Publishers | Jul 30, 2026
The payments and financial technology sector has settled on a script for AI-era workforce reductions, and Visa’s board approved it without asking who was writing the story the affected employees would read. On July 28, 2026, CEO Ryan McInerney told 2,600 employees,...
by Touch Stone Publishers | Jul 29, 2026
The Signal The FDA’s own briefing document, released two days ahead of today’s advisory committee vote, states that Capricor Therapeutics’ pivotal trial for deramiocel failed both its primary and secondary efficacy endpoints, with no statistically...
by Touch Stone Publishers | Jul 28, 2026
Every major HBM supplier on earth is sold out through 2026, and this week four hyperscalers report earnings that will show how differently each one is paying for that fact. The Supply Commitment Landed Before The Earnings Calendar Did Samsung and SK Hynix signed...
by Touch Stone Publishers | Jul 23, 2026
The Signal Houthi forces struck the Saudi flagged tanker Encelia and claimed a second strike on the tanker Layla in the Red Sea on July 22 and 23, the first attacks since the group declared a formal naval blockade against Saudi Arabia on July 20. Saudi state media...
by Touch Stone Publishers | Jul 23, 2026
Delaware barred AI from the medical license and CMS barred it from the final call, but no health system board has named who owns the agent in between. On July 1, 2026, Delaware became the first state to write into its medical practice code that an AI agent cannot be a...
by Touch Stone Publishers | Jul 22, 2026
The Signal Organon filed a Form 8-K on July 17, 2026, voluntarily supplementing its definitive Sun Pharma merger proxy statement with new synergy, valuation, and board process detail, in direct response to a still pending New Jersey injunction motion aimed at...
